Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Operating Expenses | 9,335 | 3,781 | 3,735 | 2,537 | 1,862 |
| Operating Income | -9,335 | -3,781 | -3,735 | -2,537 | -1,862 |
| Other Income | 181 | 331 | 271 | 38 | -6 |
| Pre-tax Income | -9,154 | -3,450 | -3,464 | -2,499 | -1,868 |
| Net Income Continuous | -9,154 | -3,450 | -3,464 | -2,499 | -1,868 |
| Net Income | $-9,154 | $-3,450 | $-3,464 | $-2,499 | $-1,868 |
| EPS Basic Total Ops | -1.40 | -0.50 | -0.40 | -1.00 | -1.00 |
| EPS Basic Continuous Ops | -1.39 | -0.54 | -0.38 | -0.98 | -0.99 |
| EPS Diluted Total Ops | -1.40 | -0.50 | -0.40 | -1.00 | -1.00 |
| EPS Diluted Continuous Ops | -1.39 | -0.54 | -0.38 | -0.98 | -0.99 |
| EBITDA(a) | $-9,190 | $-3,649 | $-3,547 | $-2,426 | $-1,757 |